News

November 18, 2024
Business Wire
Artificial Intelligence

CapeStart Debuts MadeAi™, its GenAI-enabled Platform for Life Sciences that Transforms Literature Review and other Applications

At the ISPOR Europe 2024 Conference today, CapeStart, Inc. debuted MadeAi™—a generative AI-based platform that dramatically streamlines the synthesis of clinical information—with its first solution, MadeAi-LR. Supporting literature review, MadeAi-LR unlocks efficiency...

November 18, 2024
Business Wire
Artificial Intelligence

BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations

BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence software, designed to transform prenatal ultrasound...

November 18, 2024
PRNewswire
Healthcare

New Report from Clarivate and Healthcare Executive Explores Mainland China’s Biopharma Revolution and Increasing Global Influence

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade...

November 18, 2024
PRNewswire
Blockchain Technology

Quantoz Payments Issues Euro and US Dollar Stablecoins; Receives Backing from Major Crypto-Asset Firms

Quantoz Payments B.V. (Quantoz), the Netherlands headquartered payments technology company, is pleased to announce that it will start issuing two stablecoins EURQ and USDQ, designed to be MiCAR Compliant, on Monday...

November 18, 2024
PRNewswire
Biotechnology

AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer

AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant high grade serous...

November 18, 2024
Business Wire
Joint Ventures

Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama

Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis laboratories, today announces...

November 18, 2024
PRNewswire
Healthcare

Law Offices of Jason Turchin Represents Victims of Defective Medical Devices

The Law Offices of Jason Turchin is representing victims injured by defective medical devices, including faulty implants, surgical tools, and more. Defective medical devices can lead to severe injuries, long-term health issues,...

November 18, 2024
Business Wire
Biotechnology

Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, announced that the National Cancer Institute awarded the Phase I portion ($400K) of the...

November 15, 2024
PRNewswire
Blockchain Technology

Cango Inc. Completes Cash-Settled Acquisitions of Crypto Mining Assets

Cango Inc. (NYSE: CANG) (“Cango” or the “Company”), a leading automotive transaction service platform in China, today announced that it has completed the previously announced acquisition of on-rack crypto mining machines with an aggregate hashrate...

November 15, 2024
Business Wire
Blockchain Technology

Kontrol Technologies Wins Multiple City Customers for Building Decarbonization; Accelerates Bitcoin on the Balance Sheet Strategy

Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company”) operates a sustainable buildings platform for customers including REITS, municipalities, property managers and industrial and commercial buildings....